Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 7/20 | 0.76 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.76 |
| ▸ | MAPT | P10636 | 3/20 | 0.76 |
| ▸ | RECQL | P46063 | 3/20 | 0.76 |
| ▸ | TDP2 | O95551 | 2/20 | 0.76 |
| ▸ | NGF | P01138 | 1/20 | 0.76 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.76 |
| ▸ | BLM | P54132 | 1/20 | 0.76 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.60 |
| ▸ | USP2 | O75604 | 4/20 | 0.60 |
| ▸ | HTT | P42858 | 3/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.60 |
| ▸ | IDO1 | P14902 | 1/20 | 0.60 |
| ▸ | HAT1 | O14929 | 4/20 | 0.55 |
| ▸ | RBBP7 | Q16576 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.55 |
| ▸ | CASP1 | P29466 | 2/20 | 0.55 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.55 |
| ▸ | CASP7 | P55210 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lumiflavin SCHEMBL29516802 | 1.00 | MEN1 (0.76) | MEN1KMT2AMAPTRECQLTDP2 | |
| Lumiflavin SCHEMBL6365933 | 0.98 | MEN1 (0.74) | MEN1KMT2AMAPTRECQLTDP2 | |
| Lumiflavin SCHEMBL6373617 | 0.97 | MEN1 (0.72) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL864918 | 0.89 | MEN1 (0.69) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL9022677 | 0.89 | MEN1 (0.69) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL16557144 | 0.86 | MEN1 (0.66) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL15683182 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL10285873 | 0.86 | MEN1 (0.66) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL29375964 | 0.86 | MEN1 (1.00) | MEN1KMT2AMAPTRECQLTDP2 | |
| SCHEMBL13955810 | 0.85 | MEN1 (0.61) | MEN1KMT2AMAPTRECQLTDP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 928 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12571758-B2 | Glucose redox reaction and composition for glucose measurement using flavin compound | KIKKOMAN CORPORATION (JP) | 2026-03-10 | — | — | US | claimed |
| US-20250362307-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | LIAO JUNG CHI (TW) | 2025-11-27 | — | — | US | claimed |
| US-12376601-B2 | Systems and method for removing the yellow color of riboflavin from lactose solutions | SPX FLOW TECHNOLOGY DANMARK A/S (DK) | 2025-08-05 | — | — | US | claimed |
| EP-3976197-B1 | THERAPEUTICS AND METHODS FOR PREDICTING AND OVERCOMING ENDOCRINE RESISTANCE IN BREAST CANCER | LUNELLA BIOTECH INC (CA) | 2025-07-16 | — | — | EP | claimed |
| EP-3934594-B1 | ENERGY AUGMENTATION STRUCTURES FOR USE IN NON-INVASIVE IN-SITU PHOTOBIOMODULATION | IMMUNOLIGHT LLC (US) | 2025-05-28 | — | — | EP | claimed |
| US-20250143897-A1 | STENT-CONTAINING MEDICAL DEVICES AND METHODS OF USING THE SAME | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2025-05-08 | — | — | US | claimed |
| EP-4473309-A1 | PHOTOACTIVE ANTIBODY CONJUGATE | Syncell (Taiwan) Inc. (TW) | 2024-12-11 | — | — | EP | claimed |
| EP-3367890-B1 | A PHOTOACTIVATABLE DRUG FOR USE IN RADIOTHERAPY | IMMUNOLIGHT LLC (US) | 2024-12-04 | — | — | EP | claimed |
| US-12121746-B2 | Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in methods and systems for treating cell proliferation disorders | IMMUNOLIGHT, LLC (US) | 2024-10-22 | — | — | US | claimed |
| US-11992697-B2 | X-ray psoralen activated cancer therapy (X-PACT) | IMMUNOLIGHT, LLC | 2024-05-28 | — | — | US | claimed |
| EP-1047458-A2 | METHOD FOR INACTIVATION OF MICROORGANISMS USING PHOTOSENSITIZERS | Gambro, Inc., (US) | 2000-11-02 | — | — | EP | claimed |
| WO-2000004930-A2 | METHOD FOR INACTIVATION OF MICROORGANISMS USING PHOTOSENSITIZERS | GAMBRO, INC. (US) | 2000-02-03 | — | — | WO | claimed |
| WO-2000004210-A2 | CMOS COMPATIBLE IDENTIFICATION OF PROCESS FLUIDS | ROBERT BOSCH GMBH (DE) | 2000-01-27 | — | — | WO | claimed |
| US-5834198-A | PHOTOOXIDATION | BOEHRINGER MAMNNHEIM GMBH (DE) | 1998-11-10 | — | — | US | claimed |
| EP-0801072-A2 | Selective photoinduced flavin-dependent cleavage of rna at g-u base pairs | Roche Diagnostics GmbH (DE) | 1997-10-15 | — | — | EP | claimed |
| EP-0739208-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1996-10-30 | — | — | EP | claimed |
| WO-1995011028-A1 | FLAVIN DERIVATIVES AS ANTI-VIRAL AGENTS | RADOPATH LIMITED (GB) | 1995-04-27 | — | — | WO | claimed |
| WO-1993010784-A1 | THERAPEUTIC COMPOSITION AND METHOD FOR PREVENTING REPERFUSION INJURY | UNIVERSITY OF MICHIGAN (US) | 1993-06-10 | — | — | WO | claimed |
| US-5153236-A | Comprising an N-aryl-alpha-amino acid and a photosensitizer such as a thixoanthone, isoalloxazine or coumarine; high sensitivity to UV and visible light; storage stability; photoresists; relief images | HITACHI CHEMICAL CO., LTD. (JP) | 1992-10-06 | — | — | US | claimed |
| US-4749670-A | Selective regeneration of mediators in the presence of a catalyst and surfactant | BASF AKTIENGESELLSCHAFT (DE) | 1988-06-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12571758-B2 | Glucose redox reaction and composition for glucose measurement using flavin compound | G6PD, TKFC, UGDH | MEN1 3734/4885KMT2A 3438/4885MAPT 1740/4885 |
| US-12121746-B2 | Energy augmentation structures, energy emitters or energy collectors containing the same, and their use in methods and systems for treating cell proliferation disorders | TK2, GFM1, HDGF | MEN1 1291/4885KMT2A 4191/4885MAPT 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.